Literature DB >> 26374915

Chronic Inotropic Therapy in the Current Era: Old Wines With New Pairings.

Sean P Pinney1, Lynne Warner Stevenson2.   

Abstract

Keywords:  Editorials; heart failure; inotropes; palliative care

Mesh：

Substances：

Year:  2015        PMID： 26374915     DOI： 10.1161/CIRCHEARTFAILURE.115.002481

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  4 in total

Review 1.  Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure.

Authors:  Abhishek Jaiswal; Vinh Q Nguyen; Thierry H Le Jemtel; Keith C Ferdinand
Journal:  World J Cardiol       Date:  2016-07-26

2.  Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.

Authors:  Laura Caroline Tavares Hastenteufel; Nadine Clausell; Jeruza Lavanholi Neyeloff; Fernanda Bandeira Domingues; Larissa Gussatschenko Caballero; Eneida Rejane Rabelo da Silva; Lívia Adams Goldraich
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

Review 3.  Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.

Authors:  Tariq Ahmad; P Elliott Miller; Megan McCullough; Nihar R Desai; Ralph Riello; Mitchell Psotka; Michael Böhm; Larry A Allen; John R Teerlink; Giuseppe M C Rosano; Joann Lindenfeld
Journal:  Eur J Heart Fail       Date:  2019-08-13       Impact factor: 15.534

4.  Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.

Authors:  Pieter Martens; Jan Vercammen; Wendy Ceyssens; Linda Jacobs; Evert Luwel; Herwig Van Aerde; Peter Potargent; Monique Renaers; Matthias Dupont; Wilfried Mullens
Journal:  ESC Heart Fail       Date:  2018-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.